Invasive aspergillosis in patients with liver disease

References

• Segal BH, Walsh TJ. Current approaches to diagnosis and treatment of invasive aspergillosis. Am J Respir Crit Care Med 2006; 173: 707–717.
   PubMed Web of Science ®Google Scholar
• Roosen J, Frans E, Wilmer A, . Comparison of premortem clinical diagnoses in critically ill patients and subsequent autopsy findings. Mayo Clin Proc 2000; 75: 562–567.
   PubMed Web of Science ®Google Scholar
• Dimopoulos G, Piagnerelli M, Berre J, . Post mortem examination in the intensive care unit: still useful? Intensive Care Med 2004; 30: 2080–2085.
   PubMedGoogle Scholar
• Meersseman W, Lagrou K, Maertens J, Van Wijngaerden E. Invasive aspergillosis in the intensive care unit. Clin Infect Dis 2007; 45: 205–216.
   PubMed Web of Science ®Google Scholar
• Cornillet A, Camus C, Nimubona S, . Comparison of epidemiological, clinical, and biological features of invasive aspergillosis in neutropenic and nonneutropenic patients: a 6-year survey. Clin Infect Dis 2006; 43: 577–584.
   PubMed Web of Science ®Google Scholar
• Panasiuk A, Wysocka J, Maciorkowska E. Phagocytic and oxidative burst activity of neutrophils in the end stage of liver cirrhosis. World J Gastroenterol. 2005; 11: 7661–7665.
   PubMed Web of Science ®Google Scholar
• Cheruvattath R, Balan V. Infections in patients with end-stage liver disease. J Clin Gastroenterol 2007; 41: 403–411.
   PubMed Web of Science ®Google Scholar
• De Pauw B, Walsh TJ, Donnelly JP, . Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008; 46: 1813–1821.
   PubMed Web of Science ®Google Scholar
• Enberg R, Bletzinger R, Burry VF. Disseminated aspergillosis during treatment of hepatic failure. J Pediatr 1973; 82: 737.
   PubMedGoogle Scholar
• Blum J, Reed JC, Pizzo SV, Thompson WM. Miliary aspergillosis associated with alcoholism. AJR Am J Roentgenol 1978; 131: 707–709.
   PubMed Web of Science ®Google Scholar
• Walsh TJ, Hutchins GM. Aspergillus mural endocarditis. Am J Clin Pathol 1979; 71: 640–644.
   PubMed Web of Science ®Google Scholar
• Brown E, Freedman S, Arbeit R, Come S. Invasive pulmonary aspergillosis in an apparently nonimmunocompromised host. Am J Med 1980; 69: 624–627.
   PubMed Web of Science ®Google Scholar
• Smith GW, Walker DH. Disseminated infection with Aspergillus flavus in an alcoholic patient. South Med J 1982; 75: 1148–1150.
   PubMedGoogle Scholar
• Park GR, Drummond GB, Lamb D, . Disseminated aspergillosis occurring in patients with respiratory, renal, and hepatic failure. Lancet 1982; 2: 179–183.
   PubMedGoogle Scholar
• Walsh TJ, Hamilton SR. Disseminated aspergillosis complicating hepatic failure. Arch Intern Med 1983; 143: 1189–1191.
   PubMedGoogle Scholar
• Sesma P, Alvarez JC, Llinares P, Suarez MD. Disseminated aspergillosis complicating hepatic failure. Arch Intern Med 1984; 144: 861–862.
   PubMedGoogle Scholar
• Ascah KJ, Hyland RH, Hutcheon MA, . Invasive aspergillosis in a ‘healthy’ patient. Can Med Assoc J 1984; 131: 332–335.
   PubMed Web of Science ®Google Scholar
• Wagner DK, Varkey B, Sheth NK, DaMert GJ. Epidural abscess, vertebral destruction, and paraplegia caused by extending infection from an aspergilloma. Am J Med 1985; 78: 518–522.
   PubMedGoogle Scholar
• Walsh TJ, Hier DB, Caplan LR. Fungal infections of the central nervous system: comparative analysis of risk factors and clinical signs in 57 patients. Neurology 1985; 35:1654–1657.
   PubMed Web of Science ®Google Scholar
• Karam GH, Griffin FM Jr. Invasive pulmonary aspergillosis in nonimmunocompromised, nonneutropenic hosts. Rev Infect Dis 1986; 8: 357–363.
   PubMedGoogle Scholar
• Watanabe A, Fujiwara M, Nagashima H. Aspergillosis in acute hepatic failure. J Med 1987; 18: 17–22.
   PubMedGoogle Scholar
• Brems JJ, Hiatt JR, Klein AS, . Disseminated aspergillosis complicating orthotopic liver transplantation for fulminant hepatic failure refractory to corticosteroid therapy. Transplantation 1988; 46: 479–481.
   PubMedGoogle Scholar
• Rolando N, Harvey F, Brahm J, . Fungal infection: a common, unrecognised complication of acute liver failure. J Hepatol 1991; 12: 1–9.
   PubMed Web of Science ®Google Scholar
• Kreisel W. Therapy of invasive aspergillosis with itraconazole: our own experiences and review of the literature. Mycoses 1994; 37: 42–51.
   PubMedGoogle Scholar
• Lim HL, Lau GK, Davis GL, . Cholestatic hepatitis leading to hepatic failure in a patient with organ-transmitted hepatitis C virus infection. Gastroenterology 1994; 106: 248–251.
   PubMed Web of Science ®Google Scholar
• Kawamura S, Maesaki S, Omagari K, . Invasive pulmonary aspergillosis diagnosed early by polymerase chain reaction assay. Intern Med 1999; 38: 744–746.
   PubMedGoogle Scholar
• Kleinschmidt-DeMasters BK. Central nervous system aspergillosis: a 20-year retrospective series. Hum Pathol 2002; 33: 116–124.
   PubMed Web of Science ®Google Scholar
• Bond R, Walter A, Trigg ME. Severe aplastic anemia associated with hepatitis and complicated by pulmonary aspergillosis: response to immune suppression and antifungal therapy. Del Med J 2002; 74: 339–343.
   PubMedGoogle Scholar
• Dimopoulos G, Piagnerelli M, Berré J, . Disseminated aspergillosis in intensive care unit patients: an autopsy study. J Chemother 2003; 15: 71–75.
   PubMed Web of Science ®Google Scholar
• Vandewoude K, Blot S, Benoit D, . Invasive aspergillosis in critically ill patients: analysis of risk factors for acquisition and mortality. Acta Clin Belg 2004; 59: 251–257.
   PubMed Web of Science ®Google Scholar
• Meersseman W, Vandecasteele SJ, Wilmer A, . Invasive aspergillosis in critically ill patients without malignancy. Am J Respir Crit Care Med 2004; 170: 621–625.
   PubMed Web of Science ®Google Scholar
• Scott JX, Kumar TS, Sanghi S, . Pulmonary aspergillosis in a child with hepatic failure. Indian J Gastroenterol 2004; 23: 147–148.
   PubMedGoogle Scholar
• Alderson JW, Van Dinter TG Jr, Opatowsky MJ, Burton EC. Disseminated aspergillosis following infliximab therapy in an immunosuppressed patient with Crohn's disease and chronic hepatitis C: a case study and review of the literature. Med Gen Med 2005; 7: 7.
   PubMedGoogle Scholar
• Lipke AB, Mihas AA. Non-decompensated cirrhosis as a risk factor for invasive aspergillosis: a case report and review of the immune dysfunction of cirrhosis. Am J Med Sci 2007; 334: 314–316.
   PubMed Web of Science ®Google Scholar
• Prodanovic H, Cracco C, Massard J, . Invasive pulmonary aspergillosis in patients with decompensated cirrhosis: case series. BMC Gastroenterol 2007; 7: 2.
   PubMedGoogle Scholar
• Li D, Chen L, Ding X, . Hospital-acquired invasive pulmonary aspergillosis in patients with hepatic failure. BMC Gastroenterol 2008; 8: 32.
   PubMedGoogle Scholar
• Meersseman W, Lagrou K, Maertens J, . Galactomannan in bronchoalveolar lavage fluid: a tool for diagnosing aspergillosis in intensive care unit patients. Am J Respir Crit Care Med 2008; 177: 27–34.
   PubMed Web of Science ®Google Scholar
• Kaiser P, Thurnheer R, Moll C, . Invasive aspergillosis in non-neutropenic patients. Eur J Intern Med 2009; 20: 131–133.
   Google Scholar
• Sykia A, Gigi E, Sinakos E, . Severe autoimmune hemolytic anemia complicated with liver decompensation and invasive aspergillosis in a patient with chronic hepatitis C during treatment with peg-interferon-a and ribavirin. J Gastrointestin Liver Dis 2009; 18: 118–119.
   PubMed Web of Science ®Google Scholar
• Bulpa P, Dive A, Sibille Y. Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease. Eur Respir J 2007; 30: 782–800.
   PubMed Web of Science ®Google Scholar
• Fiuza C, Salcedo M, Clemente G, Tellado JM. In vivo neutrophil dysfunction in cirrhotic patients with advanced liver disease. J Infect Dis 2000; 182: 526–533.
   PubMed Web of Science ®Google Scholar
• Lombardo L, Capaldi A, Poccardi G, Vineis P. Peripheral blood CD3 and CD4 T-lymphocyte reduction correlates with severity of liver cirrhosis. Int J Clin Lab Res 1995; 25: 153–156.
   PubMedGoogle Scholar
• Balloy V, Huerre M, Latge JP, Chignard M. Differences in patterns of infection and inflammation for corticosteroid treatment and chemotherapy in experimental invasive pulmonary aspergillosis. Infect Immun 2005; 73: 494–503.
   PubMed Web of Science ®Google Scholar
• Kwak EJ, Husain S, Obman A, . Efficacy of galactomannan antigen in the Platelia Aspergillus enzyme immunoassay for diagnosis of invasive aspergillosis in liver transplant recipients. J Clin Microbiol 2004; 42: 435–438.
   PubMed Web of Science ®Google Scholar
• Kimura SI, Odawara J, Aoki T, . Detection of sputum Aspergillus galactomannan for diagnosis of invasive pulmonary aspergillosis in haematological patients. Int J Hematol 2009; 90: 463–470.
   PubMed Web of Science ®Google Scholar
• Walsh TJ, Anaissie EJ, Denning DW, . Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 2008; 46: 327–360.
   PubMed Web of Science ®Google Scholar
• Angeli P, Merkel C. Pathogenesis and management of hepatorenal syndrome in patients with cirrhosis. J Hepatol 2008; 48(Suppl. 1): S93–103.
   Google Scholar
• Cannon JP, Garey KW, Danziger LH. A prospective and retrospective analysis of the nephrotoxicity and efficacy of lipid-based amphotericin B formulations. Pharmacotherapy 2001; 21: 1107–1114.
   PubMed Web of Science ®Google Scholar
• Betts R, Glasmacher A, Maertens J, . Efficacy of caspofungin against invasive Candida or invasive Aspergillus infections in neutropenic patients. Cancer 2006; 106: 466–473.
   PubMed Web of Science ®Google Scholar
• Zaoutis TE, Jafri HS, Huang LM, . A prospective, multicenter study of caspofungin for the treatment of documented Candida or Aspergillus infections in pediatric patients. Pediatrics 2009; 123: 877–884.
   PubMed Web of Science ®Google Scholar